ClearPoint Neuro, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Note 7 - Stockholders' Equity (Details) - Changes in Fair Values of Warrants Issued

Note 7 - Stockholders' Equity (Details) - Changes in Fair Values of Warrants Issued (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Note 7 - Stockholders' Equity (Details) - Changes in Fair Values of Warrants Issued [Line Items]
Balance at January 1, 2013	$ 3,747,858us-gaap_DerivativeLiabilitiesCurrent	$ 2,128,302us-gaap_DerivativeLiabilitiesCurrent
Change in fair value	(1,549,696)	(1,686,478)
Balance, shares	2,198,162us-gaap_DerivativeLiabilitiesCurrent	3,747,858us-gaap_DerivativeLiabilitiesCurrent
Warrant [Member]
Note 7 - Stockholders' Equity (Details) - Changes in Fair Values of Warrants Issued [Line Items]
Balance at January 1, 2013	3,747,858
Fair value of January 2013 warrants at transaction date		3,305,245
Change in fair value	(1,549,696)	(1,685,689)
Balance, shares	$ 2,198,162	$ 3,747,858

- Definition

Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.

+ References + Details